Literature DB >> 8350414

Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.

Y Luo1, S J Madore, T G Parslow, B R Cullen, B M Peterlin.   

Abstract

Transcriptional trans-activation of the human immunodeficiency virus type 1 long terminal repeat requires that the virally encoded Tat effector interacts with its target trans-activation response element (TAR) RNA stem-loop. Although the arginine-rich region of Tat from amino acids 49 to 59 is sufficient to bind to TAR RNA in vitro, the RNA-binding domain of Tat has not been defined in vivo. Human immunodeficiency virus type 1 also encodes the Rev protein, which acts through an RNA stem-loop called the Rev-response element to transport unspliced and singly spliced viral RNA species from the nucleus to the cytoplasm. To map the RNA-binding domain of Tat, we performed assays that relied on Rev function using the heterologous RNA-tethering mechanism of Tat and the TAR. By examining the effects of selected targeted mutations of Tat on the abilities of hybrid Tat/Rev proteins to rescue the expression of unspliced mRNA via the TAR, we demonstrated that residues throughout the N-terminal 59 amino acids of Tat are required for binding of Tat and TAR RNA in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350414      PMCID: PMC237965     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.

Authors:  A P Rice; F Carlotti
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 2.  Tat and Rev: positive regulators of HIV gene expression.

Authors:  C A Rosen; G N Pavlakis
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

3.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

Authors:  K M Weeks; C Ampe; S C Schultz; T A Steitz; D M Crothers
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

4.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.

Authors:  M H Malim; B R Cullen
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

5.  Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.

Authors:  M J Selby; B M Peterlin
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

6.  RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.

Authors:  G J Graham; J J Maio
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.

Authors:  B J Calnan; S Biancalana; D Hudson; A D Frankel
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

8.  A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot.

Authors:  T Huet; M C Dazza; F Brun-Vézinet; G E Roelants; S Wain-Hobson
Journal:  AIDS       Date:  1989-11       Impact factor: 4.177

9.  Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.

Authors:  T J Hope; X J Huang; D McDonald; T G Parslow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  Arginine-mediated RNA recognition: the arginine fork.

Authors:  B J Calnan; B Tidor; S Biancalana; D Hudson; A D Frankel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

View more
  17 in total

1.  The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.

Authors:  K Fujinaga; T P Cujec; J Peng; J Garriga; D H Price; X Graña; B M Peterlin
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.

Authors:  P R Bohjanen; R A Colvin; M Puttaraju; M D Been; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

4.  Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences.

Authors:  M Braddock; P Cannon; M Muckenthaler; A J Kingsman; S M Kingsman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.

Authors:  C H Herrmann; A P Rice
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.

Authors:  A Alonso; T P Cujec; B M Peterlin
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.

Authors:  Y Luo; H Yu; B M Peterlin
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

Authors:  P D Bieniasz; T A Grdina; H P Bogerd; B R Cullen
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.

Authors:  M E Garber; P Wei; V N KewalRamani; T P Mayall; C H Herrmann; A P Rice; D R Littman; K A Jones
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

10.  Comparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus.

Authors:  Yang Su; Gang Deng; Yuanming Gai; Yue Li; Yang Gao; Jiansen Du; Yunqi Geng; Qimin Chen; Wentao Qiao
Journal:  Virol J       Date:  2009-10-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.